Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

5.75USD
22 Oct 2018
Change (% chg)

$-0.78 (-11.94%)
Prev Close
$6.53
Open
$6.52
Day's High
$6.52
Day's Low
$5.60
Volume
27,418
Avg. Vol
10,197
52-wk High
$10.25
52-wk Low
$5.17

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $50.10
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -3.51 -- --
ROI: -4,400.15 0.21 14.27
ROE: -- 1.17 15.99

Earnings vs. Estimates